**Core Concept**
The question is testing the knowledge of medications used in the management of glaucoma, a group of eye conditions characterized by increased intraocular pressure (IOP) that can lead to optic nerve damage and vision loss. The pathophysiology of glaucoma involves impaired aqueous humor drainage or overproduction, leading to elevated IOP.

**Why the Correct Answer is Right**
The correct answer is a medication that reduces IOP by increasing the outflow of aqueous humor through the trabecular meshwork. This is achieved by enhancing the contractility of the ciliary muscle, which in turn increases the uveoscleral outflow. The correct drug is a carbonic anhydrase inhibitor, which also has a mild systemic effect on blood pressure and electrolyte balance.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not directly reduce IOP. Instead, it is used to treat conditions like hypertension and angina pectoris.
**Option B:** This option is incorrect because it is an anti-inflammatory agent used to treat conditions like uveitis and ocular inflammation. While it may have some effect on IOP, it is not the primary mechanism of action.
**Option C:** This option is incorrect because it is an alpha-2 adrenergic agonist used to treat conditions like ocular hypertension and glaucoma, but it works by reducing aqueous humor production, not increasing outflow.

**Clinical Pearl / High-Yield Fact**
When choosing a medication for glaucoma, it is essential to consider the patient's systemic health, including any potential interactions with other medications and the risk of adverse effects like hypotension or electrolyte imbalances.

**Correct Answer: D. Brinzolamide**